SHR-1316 Injection Clinical Trials
6 recruitingDrug
Phase 13Phase 23Phase 32
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.156 enrolled2 locationsNCT06474455
Recruiting
Phase 3
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
Advanced Cervical Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd720 enrolled1 locationNCT07168200
Recruiting
Phase 2
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Malignant Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.400 enrolled2 locationsNCT07268040
Recruiting
Phase 1Phase 2
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07229586
Recruiting
Phase 3
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled2 locationsNCT07111832
Recruiting
Phase 1
Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Widespread Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.48 enrolled1 locationNCT07009457